MedTrace Logo

Tied Tube Trial in Glaucoma Surgery

NCT05685485 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 152

Last updated 2024-08-27

No results posted yet for this study

Summary

The aim of this study is to assess whether delaying early flow through the Ahmed tube shunt may improve the post-operative surgical outcomes and provide a more predictable outcome. To assess this the investigator will conduct a, randomized prospective, multi-centered study with collaborators at WashU in St. Louis, Duke University, Indiana University and the University of Pittsburgh. Participants will be randomized to have an AGV placement with tube ligation (no-early flow) and without ligation (allowing for early flow). IOP will be measured at day one, week one, and months, one, three six, and twelve. Additionally, clinical data regarding number of glaucoma medications, and complications post-operative complications will also be collected.

Conditions

  • Glaucoma Eye
  • Ahmed Glaucoma Valve Implantation

Interventions

PROCEDURE

Standard Implantation

Traditional Ahmed plantation without vicryl ligature

PROCEDURE

Tied off Tube

Ahmed implantation with vicryl ligature

Sponsors & Collaborators

  • American Glaucoma Society

    collaborator OTHER

  • University of Pittsburgh

    collaborator OTHER

  • Washington University School of Medicine

    lead OTHER

Principal Investigators

  • James Liu, MD · Washington University St. Louis MO

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-18
Primary Completion
2024-12-18
Completion
2025-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05685485 on ClinicalTrials.gov